Search Results - "Ettrup, A."
-
1
The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
Published in European psychiatry (01-04-2021)“…Introduction The current treatment goal in Major Depressive Disorder (MDD) is functional recovery (Zimmerman M et al, 2012). However, finding the “right dose…”
Get full text
Journal Article -
2
-
3
-
4
-
5
-
6
-
7
CO66 Reduction in Migraine-Associated Burden over 24 Weeks of Treatment with Eptinezumab in Patients with Chronic Migraine
Published in Value in health (01-07-2022)Get full text
Journal Article -
8
-
9
-
10
P.051 Improvements in workplace productivity in working patients with major depressive disorder: results from the AtWoRC study
Published in European neuropsychopharmacology (01-12-2019)Get full text
Journal Article -
11
Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
Published in Neuropsychiatric disease and treatment (01-08-2019)“…To investigate the temporal interrelationship between depression severity, cognitive symptoms, and functioning in patients with major depressive disorder (MDD)…”
Get full text
Journal Article -
12
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study
Published in Journal of psychopharmacology (Oxford) (01-04-2019)“…Background: Stimulants remain the mainstay of treatment for attention-deficit hyperactivity disorder (ADHD) but are often associated with insufficient response…”
Get full text
Journal Article -
13
-
14
Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
Published in Neuropsychiatric disease and treatment (01-01-2021)“…This qualitative study explored patient perceptions of the most burdensome symptoms of major depressive disorder (MDD), the impact of symptoms on patients'…”
Get full text
Journal Article -
15
P.487 Measuring endogenous changes in serotonergic neurotransmission with [11C]Cimbi-36 positron emission tomography in humans
Published in European neuropsychopharmacology (01-12-2019)Get full text
Journal Article -
16
-
17
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
Published in Neuropsychiatric disease and treatment (01-07-2019)“…Cognitive symptoms in major depressive disorder (MDD) are common and may negatively impact clinical and functional outcomes. The Prospective Research…”
Get full text
Journal Article -
18
-
19
-
20
Evaluation of 3‑Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5‑HT7 Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs
Published in Journal of medicinal chemistry (23-04-2015)“…We have investigated several oxindole derivatives in the pursuit of a 5-HT7 receptor PET ligand. Herein the synthesis, chiral separation, and pharmacological…”
Get full text
Journal Article